British Journal of Cancer

Expression of the inhibitor of DNA-binding (ID)-1 protein as an angiogenic mediator in tumour advancement of uterine cervical cancers

M K Maw — October 28, 2008

Expression of the inhibitor of DNA-binding (ID)-1 protein as an angiogenic mediator in tumour advancement of uterine cervical cancers

British Journal of Cancer 99, 1557 (4 November 2008). doi:10.1038/sj.bjc.6604722

Authors: M K Maw, J Fujimoto & T Tamaya

Preoperative bevacizumab combined with letrozole and chemotherapy in locally advanced ER- and/or PgR-positive breast cancer: clinical and biological activity

R Torrisi — October 21, 2008

Preoperative bevacizumab combined with letrozole and chemotherapy in locally advanced ER- and/or PgR-positive breast cancer: clinical and biological activity

British Journal of Cancer 99, 1564 (4 November 2008). doi:10.1038/sj.bjc.6604741

Authors: R Torrisi, V Bagnardi, A Cardillo, F Bertolini, E Scarano, L Orlando, P Mancuso, A Luini, A Calleri, G Viale, A Goldhirsch & M Colleoni

Relationship between effects on time-to-disease progression and overall survival in studies of metastatic breast cancer

B Sherrill — October 28, 2008

Relationship between effects on time-to-disease progression and overall survival in studies of metastatic breast cancer

British Journal of Cancer 99, 1572 (4 November 2008). doi:10.1038/sj.bjc.6604759

Authors: B Sherrill, M Amonkar, Y Wu, C Hirst, S Stein, M Walker & J Cuzick

Phase I dose escalation study of telatinib (BAY 57-9352) in patients with advanced solid tumours

D Strumberg

Phase I dose escalation study of telatinib (BAY 57-9352) in patients with advanced solid tumours

British Journal of Cancer 99, 1579 (4 November 2008). doi:10.1038/sj.bjc.6604724

Authors: D Strumberg, B Schultheis, I A Adamietz, O Christensen, M Buechert, J Kraetzschmar, P Rajagopalan, M Ludwig, A Frost, S Steinbild, M E Scheulen & K Mross

Safety and outcome of definitive chemoradiotherapy in elderly patients with oesophageal cancer

D Tougeron — October 28, 2008

Safety and outcome of definitive chemoradiotherapy in elderly patients with oesophageal cancer

British Journal of Cancer 99, 1586 (4 November 2008). doi:10.1038/sj.bjc.6604749

Authors: D Tougeron, F Di Fiore, S Thureau, N Berbera, I Iwanicki-Caron, H Hamidou, B Paillot & P Michel

Cancer patients' awareness of clinical trials, perceptions on the benefit and willingness to participate: Korean perspectives

J W Kim

Cancer patients' awareness of clinical trials, perceptions on the benefit and willingness to participate: Korean perspectives

British Journal of Cancer 99, 1593 (4 November 2008). doi:10.1038/sj.bjc.6604750

Authors: J W Kim, S-J Kim, Y-H Chung, J-H Kwon, H-J Lee, Y-J Chung, Y J Kim, Do-Youn Oh, S-H Lee, D-W Kim, S-A Im, T-Y Kim, D S Heo & Y-J Bang

Abundant Fas expression by gastrointestinal stromal tumours may serve as a therapeutic target for MegaFasL

B Rikhof — October 21, 2008

Abundant Fas expression by gastrointestinal stromal tumours may serve as a therapeutic target for MegaFasL

British Journal of Cancer 99, 1600 (4 November 2008). doi:10.1038/sj.bjc.6604736

Authors: B Rikhof, W T A van der Graaf, C Meijer, P T K Le, G J Meersma, S de Jong, J A Fletcher & A J H Suurmeijer

Microsatellite instability due to hMLH1 deficiency is associated with increased cytotoxicity to irinotecan in human colorectal cancer cell lines

E Vilar — October 21, 2008

Microsatellite instability due to hMLH1 deficiency is associated with increased cytotoxicity to irinotecan in human colorectal cancer cell lines

British Journal of Cancer 99, 1607 (4 November 2008). doi:10.1038/sj.bjc.6604691

Authors: E Vilar, M Scaltriti, J Balmaña, C Saura, M Guzman, J Arribas, J Baselga & J Tabernero

Enhanced killing of androgen-independent prostate cancer cells using inositol hexakisphosphate in combination with proteasome inhibitors

J-S Diallo — October 21, 2008

Enhanced killing of androgen-independent prostate cancer cells using inositol hexakisphosphate in combination with proteasome inhibitors

British Journal of Cancer 99, 1613 (4 November 2008). doi:10.1038/sj.bjc.6604730

Authors: J-S Diallo, B Betton, N Parent, B Péant, L Lessard, C Le Page, R Bertrand, A-M Mes-Masson & F Saad

Inhibitory effect of HGF on invasiveness of aggressive MDA-MB231 breast carcinoma cells, and role of HDACs

E Ridolfi — October 21, 2008

Inhibitory effect of HGF on invasiveness of aggressive MDA-MB231 breast carcinoma cells, and role of HDACs

British Journal of Cancer 99, 1623 (4 November 2008). doi:10.1038/sj.bjc.6604726

Authors: E Ridolfi, E Matteucci, P Maroni & M A Desiderio

A genome-wide expression analysis identifies a network of EpCAM-induced cell cycle regulators

K Maaser — October 28, 2008

A genome-wide expression analysis identifies a network of EpCAM-induced cell cycle regulators

British Journal of Cancer 99, 1635 (4 November 2008). doi:10.1038/sj.bjc.6604725

Authors: K Maaser & J Borlak

Protein kinase Cδ expression in breast cancer as measured by real-time PCR, western blotting and ELISA

E McKiernan — October 28, 2008

Protein kinase Cδ expression in breast cancer as measured by real-time PCR, western blotting and ELISA

British Journal of Cancer 99, 1644 (4 November 2008). doi:10.1038/sj.bjc.6604728

Authors: E McKiernan, K O'Brien, N Grebenchtchikov, A Geurts-Moespot, A M Sieuwerts, J W M Martens, V Magdolen, D Evoy, E McDermott, J Crown, F C G J Sweep & M J Duffy

Can ABCF2 protein expression predict the prognosis of uterine cancer?

S Nishimura

Can ABCF2 protein expression predict the prognosis of uterine cancer?

British Journal of Cancer 99, 1651 (4 November 2008). doi:10.1038/sj.bjc.6604734

Authors: S Nishimura, H Tsuda, Y Miyagi, A Hirasawa, A Suzuki, F Kataoka, H Nomura, T Chiyoda, K Banno, T Fujii, N Susumu & D Aoki

Involvement of Cyr61 in growth, migration, and metastasis of prostate cancer cells

Z-J Sun — October 21, 2008

Involvement of Cyr61 in growth, migration, and metastasis of prostate cancer cells

British Journal of Cancer 99, 1656 (4 November 2008). doi:10.1038/sj.bjc.6604712

Authors: Z-J Sun, Y Wang, Z Cai, P-P Chen, X-J Tong & D Xie

Adenovirus detection in Guthrie cards from paediatric leukaemia cases and controls

G M Vasconcelos — October 28, 2008

Adenovirus detection in Guthrie cards from paediatric leukaemia cases and controls

British Journal of Cancer 99, 1668 (4 November 2008). doi:10.1038/sj.bjc.6604714

Authors: G M Vasconcelos, M Kang, M S Pombo-de-Oliveira, J D Schiffman, F Lorey, P Buffler & J L Wiemels

The T1799A point mutation is present in posterior uveal melanoma

C S Janssen — November 4, 2008

The T1799A point mutation is present in posterior uveal melanoma

British Journal of Cancer 99, 1673 (4 November 2008). doi:10.1038/sj.bjc.6604731

Authors: C S Janssen, R Sibbett, F L Henriquez, I C McKay, E G Kemp & F Roberts

Cell cycle times of short-term cultures of brain cancers as predictors of survival

C E Furneaux — October 14, 2008

Cell cycle times of short-term cultures of brain cancers as predictors of survival

British Journal of Cancer 99, 1678 (4 November 2008). doi:10.1038/sj.bjc.6604716

Authors: C E Furneaux, E S Marshall, K Yeoh, S J Monteith, P J Mews, C A Sansur, R J Oskouian, K J Sharples & B C Baguley

Restoration of caveolin-1 expression suppresses growth and metastasis of head and neck squamous cell carcinoma

H Zhang — October 28, 2008

Restoration of caveolin-1 expression suppresses growth and metastasis of head and neck squamous cell carcinoma

British Journal of Cancer 99, 1684 (4 November 2008). doi:10.1038/sj.bjc.6604735

Authors: H Zhang, L Su, S Müller, M Tighiouart, Z Xu, X Zhang, H J C Shin, J Hunt, S-Y Sun, D M Shin & Z(G) Chen

Blockade of SDF-1/CXCR4 signalling inhibits pancreatic cancer progression in vitro via inactivation of canonical Wnt pathway

Z Wang — October 28, 2008

Blockade of SDF-1/CXCR4 signalling inhibits pancreatic cancer progression in vitro via inactivation of canonical Wnt pathway

British Journal of Cancer 99, 1695 (4 November 2008). doi:10.1038/sj.bjc.6604745

Authors: Z Wang, Q Ma, Q Liu, H Yu, L Zhao, S Shen & J Yao

Prognostic implications of type and density of tumour-infiltrating lymphocytes in gastric cancer

H E Lee — October 21, 2008

Prognostic implications of type and density of tumour-infiltrating lymphocytes in gastric cancer

British Journal of Cancer 99, 1704 (4 November 2008). doi:10.1038/sj.bjc.6604738

Authors: H E Lee, S W Chae, Y J Lee, M A Kim, H S Lee, B L Lee & W H Kim

Two-marker protein profile predicts poor prognosis in patients with early rectal cancer

I Zlobec — November 4, 2008

Two-marker protein profile predicts poor prognosis in patients with early rectal cancer

British Journal of Cancer 99, 1712 (4 November 2008). doi:10.1038/sj.bjc.6604729

Authors: I Zlobec, K Baker, L Terracciano, S Peter, L Degen, C Beglinger & A Lugli

PRL-3 is essentially overexpressed in primary colorectal tumours and associates with tumour aggressiveness

D G Molleví — October 28, 2008

PRL-3 is essentially overexpressed in primary colorectal tumours and associates with tumour aggressiveness

British Journal of Cancer 99, 1718 (4 November 2008). doi:10.1038/sj.bjc.6604747

Authors: D G Molleví, A Aytes, L Padullés, M Martínez-Iniesta, N Baixeras, R Salazar, E Ramos, J Figueras, G Capella & A Villanueva

Smooth-muscle myosin mutations in hereditary non-polyposis colorectal cancer syndrome

N Vickaryous — October 21, 2008

Smooth-muscle myosin mutations in hereditary non-polyposis colorectal cancer syndrome

British Journal of Cancer 99, 1726 (4 November 2008). doi:10.1038/sj.bjc.6604737

Authors: N Vickaryous, G Polanco-Echeverry, S Morrow, N Suraweera, H Thomas, I Tomlinson & A Silver

Gene expression profiling of liver metastases from colorectal cancer as potential basis for treatment choice

M A Pantaleo — September 30, 2008

Gene expression profiling of liver metastases from colorectal cancer as potential basis for treatment choice

British Journal of Cancer 99, 1729 (4 November 2008). doi:10.1038/sj.bjc.6604681

Authors: M A Pantaleo, A Astolfi, M Nannini, P Paterini, G Piazzi, G Ercolani, G Brandi, G Martinelli, A Pession, A D Pinna & G Biasco

Aberrant methylation of the Adenomatous Polyposis Coli (APC) gene promoter is associated with the inflammatory breast cancer phenotype

I Van der Auwera — October 7, 2008

Aberrant methylation of the Adenomatous Polyposis Coli (APC) gene promoter is associated with the inflammatory breast cancer phenotype

British Journal of Cancer 99, 1735 (4 November 2008). doi:10.1038/sj.bjc.6604705

Authors: I Van der Auwera, S J Van Laere, S M Van den Bosch, G G Van den Eynden, B X Trinh, P A van Dam, C G Colpaert, M van Engeland, E A Van Marck, P B Vermeulen & L Y Dirix

Effects of G/A polymorphism, rs266882, in the androgen response element 1 of the PSA gene on prostate cancer risk, survival and circulating PSA levels

C Jesser — September 30, 2008

Effects of G/A polymorphism, rs266882, in the androgen response element 1 of the PSA gene on prostate cancer risk, survival and circulating PSA levels

British Journal of Cancer 99, 1743 (4 November 2008). doi:10.1038/sj.bjc.6604690

Authors: C Jesser, L Mucci, D Farmer, C Moon, H Li, J M Gaziano, M Stampfer, J Ma & P Kantoff

Increased prevalence of testicular microlithiasis in men with familial testicular cancer and their relatives

L A Korde — October 7, 2008

Increased prevalence of testicular microlithiasis in men with familial testicular cancer and their relatives

British Journal of Cancer 99, 1748 (4 November 2008). doi:10.1038/sj.bjc.6604704

Authors: L A Korde, A Premkumar, C Mueller, P Rosenberg, C Soho, G Bratslavsky & M H Greene

‘Second primary breast cancers following an initial diagnosis of cancer in one breast: a methodological issue’

D Robinson — October 14, 2008

‘Second primary breast cancers following an initial diagnosis of cancer in one breast: a methodological issue’

British Journal of Cancer 99, 1754 (4 November 2008). doi:10.1038/sj.bjc.6604718

Author: D Robinson

Effectiveness of service screening: a case–control study to assess breast cancer mortality reduction

D Puliti

Effectiveness of service screening: a case–control study to assess breast cancer mortality reduction

British Journal of Cancer 99, 1756 (4 November 2008). doi:10.1038/sj.bjc.6604779

Authors: D Puliti, G Miccinesi, N Collina, V De Lisi, M Federico, S Ferretti, A C Finarelli, F Foca, L Mangone, C Naldoni, M Petrella, A Ponti, N Segnan, A Sigona, M Zarcone, M Zorzi, M Zappa & E Paci